Skip to NavigationSkip to content

News

0
India and South Korea approve Gilead's remdesivir for emergency use against COVID-19
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir for emergency use in a bid...
0
Lancet expresses concern over published hydroxychloroquine and chloroquine paper
The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was dangerous...
0
The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening
The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access to hydroxychloroquine...
0
Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients
Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory failure in...
>> More News Stories

Features

How Big Brother is helping to fight COVID-19

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to...

>> More Features
>> More News Stories